Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice

Realization of the full potential of immune checkpoint inhibitor-targeted onco-immunotherapy is largely dependent on overcoming the obstacles presented by the resistance of some cancers, as well as on reducing the high frequency of immune-related adverse events (IRAEs) associated with this type of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Ronald, Rapoport, Bernardo L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874299/
https://www.ncbi.nlm.nih.gov/pubmed/29623257
http://dx.doi.org/10.3389/fonc.2018.00080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874299/
https://www.ncbi.nlm.nih.gov/pubmed/29623257
http://dx.doi.org/10.3389/fonc.2018.00080

Ejemplares similares